Efficacy of Microbiome-Targeted Interventions in Obesity Management- A comprehensive systematic review
Diabetes & Metabolic Syndrome Clinical Research & Reviews,
Journal Year:
2025,
Volume and Issue:
19(2), P. 103208 - 103208
Published: Feb. 1, 2025
Language: Английский
Role of Mitochondrial Dysfunction in Neuropathy
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3195 - 3195
Published: March 29, 2025
Diabetes
mellitus
is
characterized
by
a
state
of
hyperglycemia,
which
can
lead
to
severe
complications
if
left
untreated
or
poorly
managed.
Diabetic
peripheral
neuropathy
(DPN)
one
common
complication.
This
condition
damage
the
nerves
that
supply
legs
and
feet
as
well
problems
with
blood
vessels,
heart,
urinary
tract.
To
alleviate
pain
for
patients,
clinicians
resort
long-term
treatment
regimens
nerve
medications,
are
usually
either
anticonvulsants
antidepressants.
However,
little
understood
about
underlying
mechanisms
DPN.
Many
pathogenic
pathways
have
been
proposed,
mitochondrial
dysfunction.
Mitochondrial
dysfunction
includes
range
possible
deficiencies
given
number
functions
controlled
located
in
mitochondria,
including
their
core
function
bioenergetics.
review
focuses
on
bioenergetics,
respiration/ATP
synthesis
reactive
oxygen
species
(ROS)
production,
calcium
homeostasis
apoptosis,
potential
targets
effective
diabetic
neuropathy.
Language: Английский
Novel Polyethyleneimine-chitosan Nanoparticles Encapsulating Urolithin B: A Potential Nanotherapeutic Approach for Diabetic Nephropathy
Jose Prakash Dharmian,
No information about this author
S. P. Angelin Claret,
No information about this author
P. Ramakrishnan
No information about this author
et al.
Journal of Cluster Science,
Journal Year:
2025,
Volume and Issue:
36(2)
Published: Feb. 2, 2025
Language: Английский
Mitochondrial Dysfunction in Diabetes: Shedding Light on a Widespread Oversight
Pathophysiology,
Journal Year:
2025,
Volume and Issue:
32(1), P. 9 - 9
Published: Feb. 13, 2025
Diabetes
mellitus
represents
a
complicated
metabolic
condition
marked
by
ongoing
hyperglycemia
arising
from
impaired
insulin
secretion,
inadequate
action,
or
combination
of
both.
Mitochondrial
dysfunction
has
emerged
as
significant
contributor
to
the
aetiology
diabetes,
affecting
various
processes
critical
for
glucose
homeostasis.
This
review
aims
elucidate
complex
link
between
mitochondrial
and
covering
spectrum
diabetes
types,
role
mitochondria
in
resistance,
highlighting
pathophysiological
mechanisms,
DNA
damage,
altered
biogenesis
dynamics.
Additionally,
it
discusses
clinical
implications
complications
its
complications,
diagnostic
approaches
assessing
function
diabetics,
therapeutic
strategies,
future
directions,
research
opportunities.
Language: Английский
Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications
Asim J. Tashkandi,
No information about this author
Andrew Gorman,
No information about this author
Eva McGoldrick Mathers
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3016 - 3016
Published: March 26, 2025
The
growing
prevalence
of
diabetes
highlights
the
urgent
need
to
study
diabetic
cardiovascular
complications,
specifically
cardiomyopathy,
which
is
a
diabetes-induced
myocardial
dysfunction
independent
hypertension
or
coronary
artery
disease.
This
review
examines
role
mitochondrial
in
promoting
cardiac
and
metabolic
mechanisms
such
as
hyperglycaemia-induced
oxidative
stress.
Chronic
hyperglycaemia
insulin
resistance
can
activate
harmful
pathways,
including
advanced
glycation
end-products
(AGEs),
protein
kinase
C
(PKC)
hexosamine
signalling,
uncontrolled
reactive
oxygen
species
(ROS)
production
mishandling
Ca2+
transient.
These
processes
lead
cardiomyocyte
apoptosis,
fibrosis
contractile
dysfunction.
Moreover,
endoplasmic
reticulum
(ER)
stress
dysregulated
RNA-binding
proteins
(RBPs)
extracellular
vesicles
(EVs)
contribute
tissue
damage,
drives
function
towards
heart
failure
(HF).
Advanced
patient-derived
induced
pluripotent
stem
cell
(iPSC)
organoids
(iPS-COs)
are
transformative
tools
for
modelling
cardiomyopathy
capturing
human
disease's
genetic,
epigenetic
hallmarks.
iPS-COs
may
facilitate
precise
examination
molecular
pathways
therapeutic
interventions.
Future
research
directions
encourage
integration
models
with
mechanistic
techniques
promote
novel
strategies.
Language: Английский